Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Wanselius M"'
Autor:
Wanselius M; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden., Abrahmsén-Alami S; Innovation Strategy & External Liaison. Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden., Hanafy BI; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Cambridge, United Kingdom., Mazza M; Advanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Cambridge, United Kingdom., Hansson P; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden. Electronic address: per.hansson@ilk.uu.se.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Dec 25; Vol. 667 (Pt A), pp. 124849. Date of Electronic Publication: 2024 Oct 24.
Autor:
Wanselius M; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23 Uppsala, Sweden., Al-Tikriti Y; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23 Uppsala, Sweden., Hansson P; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23 Uppsala, Sweden. Electronic address: per.hansson@ilk.uu.se.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2023 Nov 25; Vol. 647, pp. 123517. Date of Electronic Publication: 2023 Oct 21.
Autor:
Wanselius M; Department of Medicinal Chemistry, Uppsala University, SE-751 23 Uppsala, Sweden., Rodler A; Department of Medicinal Chemistry, Uppsala University, SE-751 23 Uppsala, Sweden., Searle SS; Department of Medicinal Chemistry, Uppsala University, SE-751 23 Uppsala, Sweden., Abrahmsén-Alami S; Innovation Strategies & External Liaison, Pharmaceutical Technology & Development, Operations, AstraZeneca, SE-431 83 Gothenburg, Sweden., Hansson P; Department of Medicinal Chemistry, Uppsala University, SE-751 23 Uppsala, Sweden.
Publikováno v:
Gels (Basel, Switzerland) [Gels] 2022 Sep 15; Vol. 8 (9). Date of Electronic Publication: 2022 Sep 15.
Autor:
Wanselius M; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden., Searle S; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden., Rodler A; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden., Tenje M; Department of Material Science and Engineering, Science for Life Laboratory, Uppsala University, P.O. Box 35, SE-751 03 Uppsala, Sweden., Abrahmsén-Alami S; Innovation Strategies & External Liaison. Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden., Hansson P; Department of Medicinal Chemistry, Uppsala University, BMC P.O. Box 574, SE-751 23, Uppsala, Sweden. Electronic address: per.hansson@ilk.uu.se.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2022 Jun 10; Vol. 621, pp. 121785. Date of Electronic Publication: 2022 Apr 30.
Autor:
Bezrukov, Artem1 (AUTHOR) a.bezrukov.knrtu@yandex.ru, Galyametdinov, Yury1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13555. 18p.
Autor:
Bezrukov, Artem, Galyametdinov, Yury
Publikováno v:
Polymers (20734360); Dec2022, Vol. 14 Issue 24, p5480, 15p